Synthetic Biology Market
Synthetic Biology Market - Global Industry Assessment & Forecast
#
Pages:
173
2022
Jan - 2022
VMR-1255
Segments Covered
By
Tool Enzymes, Synthetic Cells, Oligonucleotides and Synthetic DNA, Cloning Technology Kits, Xeno-nucleic Acids, Chassis Organisms
-
By
Technology Sequencing, Cloning, Gene Synthesis, Genome Engineering, Bioinformatics, Microfluidics, Nanotechnology, Site-directed Mutagenesis, Measurement and Modelling
-
By
Application Medical Application, Industrial Application, Environmental Application, Artificial Tissue and Tissue Regeneration, Food and Agriculture
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 12.70 Billion |
 Revenue 2030:
|
USD 85.97 Billion |
 Revenue CAGR
(2023 - 2030): |
27.00% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Synthetic Biology Market by Tool by Technology by Application by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
Data Triangulation and Market Size Estimations
Vantage Market
Research | 01-Feb-2022
FAQ
Frequently Asked Question
What is the global demand for Synthetic Biology in terms of revenue?
-
The global Synthetic Biology valued at USD 12.70 Billion in 2022 and is expected to reach USD 85.97 Billion in 2030 growing at a CAGR of 27.00%.
Which are the prominent players in the market?
-
The prominent players in the market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 27.00% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Synthetic Biology include
- Rising R&D Funding and Growing Initiatives in Synthetic Biology
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Synthetic Biology in 2022.
